Who owns Talis Biomedical Corporation?
- Ticker: TLIS
- CUSIP Number: 87424l207
Tip: Access positions for across all investors
Analyze quarterly positions in Talis Biomedical Corporation with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Talis Biomedical Corporation stock
Who bought or sold Talis Biomedical Corporation this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Baker Bros. Advisors | 508k | $4.4M | 0% | Mar 2024 |
|
| Greenlight Capital | 149k | $1.1M | 0% | Dec 2023 |
|
| DME Capital Management | 149k | $1.3M | 100% | Mar 2024 |
|
| BML Capital Management | 43k | $374k | 0% | Mar 2024 |
|
| Vanguard Group | 31k | $271k | 0% | Mar 2024 |
|
| Susquehanna International | 17k | $153k | 43% | Mar 2024 |
|
| Springbok Capital Management | 15k | $131k | 0% | Mar 2024 |
|
| Geode Capital Management | 12k | $104k | 5% | Mar 2024 |
|
| BlackRock | 4.7k | $41k | -4% | Mar 2024 |
|
| Tower Research Capital | 927.00 | $8.1k | 19% | Mar 2024 |
|
| Morgan Stanley | 635.00 | $5.6k | -72% | Mar 2024 |
|
| ADAR1 Capital Management | 300.00 | $2.6k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 122.00 | $1.1k | 16% | Mar 2024 |
|
| UBS Group | 120.00 | $1.1k | -6% | Mar 2024 |
|
| Larson Financial Group | 14.00 | $122.999800 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 13.00 | $113.999600 | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 3.00 | $26.000100 | 50% | Mar 2024 |
|
| Qube Research & Technologies | 2.00 | $18.000000 | 0% | Mar 2024 |
|
Who sold out of Talis Biomedical Corporation?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2023 | 10k | $75k |
| Citigroup | Dec 2023 | 1.6k | $12k |